메뉴 건너뛰기




Volumn , Issue , 2012, Pages 331-346

Registries

Author keywords

Comparative effectiveness; Effectiveness; Pharmacoepidemiology; Pharmacovigilance; Pregnancy registry; Product safety; Registry

Indexed keywords


EID: 84888765832     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781119959946.ch21     Document Type: Chapter
Times cited : (5)

References (76)
  • 2
    • 41549117102 scopus 로고    scopus 로고
    • Observational research, randomised trials, and two views of medical science
    • Vandenbroucke J. Observational research, randomised trials, and two views of medical science . PLOS Med 2008; 5: 339-43.
    • (2008) PLOS Med , vol.5 , pp. 339-343
    • Vandenbroucke, J.1
  • 3
    • 0034702175 scopus 로고    scopus 로고
    • Randomized, controlled trials, observational studies and the hierarchy of research designs
    • Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies and the hierarchy of research designs . N Engl J Med 2000; 342: 1887-92.
    • (2000) N Engl J Med , vol.342 , pp. 1887-1892
    • Concato, J.1    Shah, N.2    Horwitz, R.I.3
  • 4
    • 57849129354 scopus 로고    scopus 로고
    • De Testimonio. On the evidence for decisions about the use of therapeutic interventions
    • Rawlins, MD, De Testimonio. On the evidence for decisions about the use of therapeutic interventions . Clin Med 2008; 8: 579-88.
    • (2008) Clin Med , vol.8 , pp. 579-588
    • Rawlins, M.D.1
  • 5
    • 36549040492 scopus 로고    scopus 로고
    • In defense of pharmacoepidemiology - embracing the yin and yang of drug research
    • Avorn J. In defense of pharmacoepidemiology - embracing the yin and yang of drug research . N Engl J Med 2007; 357: 2219-21.
    • (2007) N Engl J Med , vol.357 , pp. 2219-2221
    • Avorn, J.1
  • 6
    • 47349129001 scopus 로고    scopus 로고
    • 2nd edn . (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. dba Outcome] under Contract No. HHSA29020050035I TO1.) AHRQ Publication No. 10 -EHC049. Rockville, MD: Agency for Healthcare Research and Quality
    • Gliklich RE, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User ' s Guide, 2nd edn . (Prepared by Outcome DEcIDE Center [Outcome Sciences, Inc. dba Outcome] under Contract No. HHSA29020050035I TO1.) AHRQ Publication No. 10 -EHC049. Rockville, MD: Agency for Healthcare Research and Quality , 2010.
    • (2010) eds. Registries for Evaluating Patient Outcomes: A User ' s Guide
    • Gliklich, R.E.1    Dreyer, N.A.2
  • 7
    • 44849096465 scopus 로고    scopus 로고
    • Implications for registry -based vaccine effectiveness studies from an evaluation of an immunization registry: A cross -sectional study
    • Mahon BE, Shea KM, Dougherty NN, Loughlin AM. Implications for registry -based vaccine effectiveness studies from an evaluation of an immunization registry: A cross -sectional study . BMC Public Health 2008; 8: 160.
    • (2008) BMC Public Health , vol.8 , pp. 160
    • Mahon, B.E.1    Shea, K.M.2    Dougherty, N.N.3    Loughlin, A.M.4
  • 8
    • 0036304298 scopus 로고    scopus 로고
    • Improving accuracy in a computerized immunization registry
    • Samuels RC, Appel L, Reddy SI, Tilson RS. Improving accuracy in a computerized immunization registry . Ambul Pediatr 2002; 2: 187-92.
    • (2002) Ambul Pediatr , vol.2 , pp. 187-192
    • Samuels, R.C.1    Appel, L.2    Reddy, S.I.3    Tilson, R.S.4
  • 9
    • 0033050539 scopus 로고    scopus 로고
    • . Immunization registries in the United States: implications for the practice of public health in a changing health care system
    • Wood D, Saarlas KN, Inkelas M, Matyas BT . Immunization registries in the United States: implications for the practice of public health in a changing health care system . Annu Rev Public Health 1999; 20: 231-55.
    • (1999) Annu Rev Public Health , vol.20 , pp. 231-255
    • Wood, D.1    Saarlas, K.N.2    Inkelas, M.3    Matyas, B.T.4
  • 10
    • 0036642395 scopus 로고    scopus 로고
    • A risk model derived from the National Registry of Myocardial Infarction 2 database for predicting mortality after coronary artery bypass grafting during acute myocardial infarction
    • Zaroff JG, diTommaso DG, Barron HV . A risk model derived from the National Registry of Myocardial Infarction 2 database for predicting mortality after coronary artery bypass grafting during acute myocardial infarction . Am J Cardiol 2002; 90: 1-4.
    • (2002) Am J Cardiol , vol.90 , pp. 1-4
    • Zaroff, J.G.1    diTommaso, D.G.2    Barron, H.V.3
  • 11
    • 84881382048 scopus 로고    scopus 로고
    • Cystic Fibrosis Foundation (accessed May)
    • Cystic Fibrosis Foundation . Patient Registry Report. www.cff.org/LivingWithCF/QualityImprovement/ PatientRegistryReport (accessed May, 2010).
    • (2010) Patient Registry Report
  • 12
    • 77956988482 scopus 로고    scopus 로고
    • Effectiveness of antiviral treatment in human influenza H5N1 infections: analysis from a global patient registry
    • Adisasmito W, Chan PKS, Lee N, Oner AF , Gasimov V, Aghayev F, et al. Effectiveness of antiviral treatment in human influenza H5N1 infections: analysis from a global patient registry . J Infect Dis 2010; 202: 1154-60.
    • (2010) J Infect Dis , vol.202 , pp. 1154-1160
    • Adisasmito, W.1    Chan, P.K.S.2    Lee, N.3    Oner, A.F.4    Gasimov, V.5    Aghayev, F.6
  • 14
    • 0015225140 scopus 로고
    • Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women
    • Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women . N Engl J Med 1971; 284: 878-81.
    • (1971) N Engl J Med , vol.284 , pp. 878-881
    • Herbst, A.L.1    Ulfelder, H.2    Poskanzer, D.C.3
  • 15
    • 0015519148 scopus 로고
    • Clear -cell adenocarcinomas of the genital tract in young females, Registry report
    • Herbst AL, Kurman RJ, Scully RE. Clear -cell adenocarcinomas of the genital tract in young females. Registry report . N Engl J Med 1972; 287: 1259-64.
    • (1972) N Engl J Med , vol.287 , pp. 1259-1264
    • Herbst, A.L.1    Kurman, R.J.2    Scully, R.E.3
  • 16
    • 0034626360 scopus 로고    scopus 로고
    • The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher disease
    • Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, et al. The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher disease . Arch Intern Med 2000; 160: 2835-43.
    • (2000) Arch Intern Med , vol.160 , pp. 2835-2843
    • Charrow, J.1    Andersson, H.C.2    Kaplan, P.3    Kolodny, E.H.4    Mistry, P.5    Pastores, G.6
  • 18
    • 60649117968 scopus 로고    scopus 로고
    • Stenting and angioplasty with protecting in patients at high -risk for endarterectomy: SAPPHIRE worldwide registry first 2,001 patients
    • Massop D, Dave R, Metzger C, Bachinsky W, Solis M, Shah R, et al. Stenting and angioplasty with protecting in patients at high -risk for endarterectomy: SAPPHIRE worldwide registry first 2,001 patients . Catheter Cardiovasc Interv 2009; 73: 129-36.
    • (2009) Catheter Cardiovasc Interv , vol.73 , pp. 129-136
    • Massop, D.1    Dave, R.2    Metzger, C.3    Bachinsky, W.4    Solis, M.5    Shah, R.6
  • 19
    • 75249099806 scopus 로고    scopus 로고
    • Are quality improvements associated with the Get With the Guidelines -Coronary Artery Disease (GWTG -CAD) program sustained over time? A longitudinal comparison of GWTG -CAD hospitals versus non -GWTG-CAD hospitals
    • Xian Y, Pan W, Peterson ED, Heidenreich PA , Cannon CP , Hernandez AF , et al. Are quality improvements associated with the Get With the Guidelines -Coronary Artery Disease (GWTG -CAD) program sustained over time? A longitudinal comparison of GWTG -CAD hospitals versus non -GWTG-CAD hospitals . Am Heart J 2010; 159: 207-14.
    • (2010) Am Heart J , vol.159 , pp. 207-214
    • Xian, Y.1    Pan, W.2    Peterson, E.D.3    Heidenreich, P.A.4    Cannon, C.P.5    Hernandez, A.F.6
  • 20
    • 84888681739 scopus 로고    scopus 로고
    • Illinois Comprehensive Automated Immunization Registry Exchange (I - CARE) Fact Sheet
    • Illinois Department of Public Health (accessed Aug.)
    • Illinois Department of Public Health . Illinois Comprehensive Automated Immunization Registry Exchange (I - CARE) Fact Sheet. http://www.idph. state.il.us/health/vaccine/icarefs.html (accessed Aug., 2010).
    • (2010)
  • 21
    • 39749089389 scopus 로고    scopus 로고
    • ISPE. Guidelines for good pharmacoepidemiology practices (GPP)
    • ISPE. Guidelines for good pharmacoepidemiology practices (GPP) . Pharmacoepidemiol Drug Saf 2008; 17: 200-8.
    • (2008) Pharmacoepidemiol Drug Saf , vol.17 , pp. 200-208
  • 23
    • 35848948166 scopus 로고    scopus 로고
    • The strengthening the report ing of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
    • Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzche PC, Vandenbroucke JP . The strengthening the report ing of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies . Ann Intern Med 2007; 147: 573-7.
    • (2007) Ann Intern Med , vol.147 , pp. 573-577
    • Von Elm, E.1    Altman, D.G.2    Egger, M.3    Pocock, S.J.4    Gotzche, P.C.5    Vandenbroucke, J.P.6
  • 24
    • 77954108319 scopus 로고    scopus 로고
    • on behalf of the GRACE Initiative, GRACE principles: recognizing high -quality observational studies of comparative effectiveness
    • Dreyer NA, Schneeweiss S, McNeil B, Berger ML, Walker A, et al, on behalf of the GRACE Initiative. GRACE principles: recognizing high -quality observational studies of comparative effectiveness . Am J Manag Care 2010; 16: 467-71.
    • (2010) Am J Manag Care , vol.16 , pp. 467-471
    • Dreyer, N.A.1    Schneeweiss, S.2    McNeil, B.3    Berger, M.L.4    Walker, A.5
  • 25
    • 0032557175 scopus 로고    scopus 로고
    • Variation in carotid endarterectomy mortality in the medicare population: trial hospitals, volume, and patient characteristics
    • Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the medicare population: trial hospitals, volume, and patient characteristics . JAMA 1998; 279: 1278-81.
    • (1998) JAMA , vol.279 , pp. 1278-1281
    • Wennberg, D.E.1    Lucas, F.L.2    Birkmeyer, J.D.3    Bredenberg, C.E.4    Fisher, E.S.5
  • 27
    • 84888753389 scopus 로고    scopus 로고
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases, US Department of Health and Human Services (accessed May)
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases, US Department of Health and Human Services . Patient Research Registries. http:// www.niams.nih.gov/Funding/Funded_Research/ registries.asp (accessed May, 2010).
    • (2010) Patient Research Registries
  • 28
    • 84888719266 scopus 로고    scopus 로고
    • Surveillance, Epidemiology, and End Results
    • National Cancer Institute (accessed May)
    • National Cancer Institute . Surveillance, Epidemiology, and End Results. Overview of the SEER Program. http:// seer.cancer.gov/about/ (accessed May, 2010).
    • (2010) Overview of the SEER Program
  • 29
    • 0022481337 scopus 로고
    • Oral contraceptive use and risk of breast cancer
    • Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development
    • Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development . Oral contraceptive use and risk of breast cancer . N Engl J Med 1986; 315: 405-11.
    • (1986) N Engl J Med , vol.315 , pp. 405-411
  • 30
    • 0020676322 scopus 로고
    • Oral contraceptive use and the risk of ovarian cancer
    • Anon
    • Anon. Oral contraceptive use and the risk of ovarian cancer . JAMA 1983; 249: 1596-9.
    • (1983) JAMA , vol.249 , pp. 1596-1599
  • 31
    • 0020691964 scopus 로고
    • Oral contraceptive use and the risk of endometrial cancer
    • Anon
    • Anon. Oral contraceptive use and the risk of endometrial cancer . JAMA 1983; 249: 1600-4.
    • (1983) JAMA , vol.249 , pp. 1600-1604
  • 33
    • 39249084652 scopus 로고    scopus 로고
    • Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States
    • Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States . Gynecol Oncol 2008; 108: 577-83.
    • (2008) Gynecol Oncol , vol.108 , pp. 577-583
    • Stroup, A.M.1    Harlan, L.C.2    Trimble, E.L.3
  • 34
    • 39049180984 scopus 로고    scopus 로고
    • Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975 -1999
    • Mariotto AB, Feuer EJ, Harlan LC, Abrams J. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975 -1999. J Natl Cancer Inst Monogr 2006; 36: 7-15.
    • (2006) J Natl Cancer Inst Monogr , vol.36 , pp. 7-15
    • Mariotto, A.B.1    Feuer, E.J.2    Harlan, L.C.3    Abrams, J.4
  • 35
    • 84888757544 scopus 로고    scopus 로고
    • Surveillance, Epidemiology, and End Results Program
    • National Cancer Institute (accessed May)
    • National Cancer Institute . Surveillance, Epidemiology, and End Results Program. SEER - Medicare Linked Database. http://seer.cancer.gov/about/seermedicare. html (accessed May, 2010).
    • (2010) SEER - Medicare Linked Database
  • 36
    • 68049125885 scopus 로고    scopus 로고
    • Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer
    • discussion 1064
    • Cheung WY , Neville BA, Earle CC. Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer . Dis Colon Rectum 2009; 52: 1054-63; discussion 1064.
    • (2009) Dis Colon Rectum , vol.52 , pp. 1054-1063
    • Cheung, W.Y.1    Neville, B.A.2    Earle, C.C.3
  • 37
    • 69249144492 scopus 로고    scopus 로고
    • Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women
    • Hershman DL, Buono D, McBride RB, Tsai WY , Neugut AI. Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women . Cancer 2009; 115: 3848-57.
    • (2009) Cancer , vol.115 , pp. 3848-3857
    • Hershman, D.L.1    Buono, D.2    McBride, R.B.3    Tsai, W.Y.4    Neugut, A.I.5
  • 38
    • 69849097151 scopus 로고    scopus 로고
    • Hospital factors and racial disparities in mortality after surgery for breast and colon cancer
    • Breslin TM, Morris AM, Gu N, Wong SL, Finlayson EV , Banerjee M, et al. Hospital factors and racial disparities in mortality after surgery for breast and colon cancer . J Clin Oncol 2009; 27: 3945-50.
    • (2009) J Clin Oncol , vol.27 , pp. 3945-3950
    • Breslin, T.M.1    Morris, A.M.2    Gu, N.3    Wong, S.L.4    Finlayson, E.V.5    Banerjee, M.6
  • 39
    • 77950595853 scopus 로고    scopus 로고
    • Differences in melanoma outcomes among Hispanic Medicare enrollees
    • Rouhani P, Arheart KL, Kirsner RS. Differences in melanoma outcomes among Hispanic Medicare enrollees. J Am Acad Dermatol 2010; 62: 768-76.
    • (2010) J Am Acad Dermatol , vol.62 , pp. 768-776
    • Rouhani, P.1    Arheart, K.L.2    Kirsner, R.S.3
  • 40
    • 84888691251 scopus 로고    scopus 로고
    • US Hereditary Angioedema Association (accessed June)
    • US Hereditary Angioedema Association . US HAE Scientific Registry: Patient Driven Research for a Cure. http://www.haea.org/get -involved/us-haea-scientific -registry/ (accessed June 2011).
    • (2011) US HAE Scientific Registry: Patient Driven Research for a Cure
  • 41
    • 68949121335 scopus 로고    scopus 로고
    • Registries for robust evidence
    • Dreyer NA, Garner S. Registries for robust evidence . JAMA 2009; 302: 790-1.
    • (2009) JAMA , vol.302 , pp. 790-791
    • Dreyer, N.A.1    Garner, S.2
  • 42
    • 65249143891 scopus 로고    scopus 로고
    • Clinical effectiveness of coronary stents in the elderly: results from 262, 700 Medicare patients in ACC -NCDR
    • Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, et al. Clinical effectiveness of coronary stents in the elderly: results from 262,700 Medicare patients in ACC -NCDR. J Am Coll Cardiol 2009; 53: 1629-41.
    • (2009) J Am Coll Cardiol , vol.53 , pp. 1629-1641
    • Douglas, P.S.1    Brennan, J.M.2    Anstrom, K.J.3    Sedrakyan, A.4    Eisenstein, E.L.5
  • 43
    • 84888667035 scopus 로고    scopus 로고
    • Food and Drug Administration, United States Department of Health and Human Services
    • Center for Biologics Evaluation and Research (CBER) (accessed May)
    • Center for Biologics Evaluation and Research (CBER) , Food and Drug Administration, United States Department of Health and Human Services. Guidance for Industry: Gene Therapy Clinical Trials - Observing Subjects for Delayed Adverse Events. http://www.fda.gov/BiologicsBlood Vaccines/GuidanceComplianceRegulatoryIn formation/ Guidances/CellularandGeneTherapy/ucm072957.htm (accessed May, 2010).
    • (2010) Guidance for Industry: Gene Therapy Clinical Trials - Observing Subjects for Delayed Adverse Events
  • 44
    • 84888731146 scopus 로고    scopus 로고
    • European Medicines Agency. Guideline on Safety and Efficacy Follow - Up - Risk Management of Advanced Therapy Medicinal Products
    • Committee for Medicinal Products for Human Use (CHMP), Doc. Ref. EMEA/149995/2008
    • Committee for Medicinal Products for Human Use (CHMP). Guideline on Safety and Efficacy Follow - Up - Risk Management of Advanced Therapy Medicinal Products, Doc. Ref. EMEA/149995/2008 . European Medicines Agency, 2008.
    • (2008)
  • 45
    • 84888679079 scopus 로고    scopus 로고
    • Registries rising: FDA looking at TNF inhibitors; AHRQ updates standards
    • Hobbs MN. Registries rising: FDA looking at TNF inhibitors; AHRQ updates standards . Pink Sheet 2009; 71: 8-9.
    • (2009) Pink Sheet , vol.71 , pp. 8-9
    • Hobbs, M.N.1
  • 46
    • 77953643565 scopus 로고    scopus 로고
    • Framework for evidence evaluation and methodological issues in implantable device studies
    • Sedrakyan A, Marinac-Dabic D, Normand SL, Mushlin A, Gross T. Framework for evidence evaluation and methodological issues in implantable device studies. Med Care 2010; 48 (6 Suppl): S121-8.
    • (2010) Med Care , vol.48 , Issue.6 SUPPL.
    • Sedrakyan, A.1    Marinac-Dabic, D.2    Normand, S.L.3    Mushlin, A.4    Gross, T.5
  • 47
    • 84888652015 scopus 로고    scopus 로고
    • Food and Drug Administration, United States Department of Health and Human Services (accessed April)
    • Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER)
    • Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Guidance for Industry: Establishing Pregnancy Exposure Registries. Food and Drug Administration, United States Department of Health and Human Services. http://www.fda.gov/downloads/ Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM071639.pdf(accessed April, 2010).
    • (2010) Guidance for Industry: Establishing Pregnancy Exposure Registries
  • 48
    • 84888717067 scopus 로고    scopus 로고
    • Guideline on the Exposure to Medicinal Products During Pregnancy: Need for Post - Authorisation Data
    • Committee for Medicinal Products for Human Use (CHMP), EMEA/CHMP/313666/2005. European Medicines Agency, Adopted November 2005 (accessed April)
    • Committee for Medicinal Products for Human Use (CHMP). Guideline on the Exposure to Medicinal Products During Pregnancy: Need for Post - Authorisation Data, EMEA/CHMP/313666/2005. European Medicines Agency, Adopted November 2005. http://www. ema.europa.eu/pdfs/human/phvwp/31366605en.pdf(accessed April, 2010).
    • (2010)
  • 50
    • 71549141310 scopus 로고    scopus 로고
    • Population-based study of antiepileptic drug exposure in utero - influence on head circumference in newborns
    • Almgren M, Källén B, Lavebratt C. Population-based study of antiepileptic drug exposure in utero - influence on head circumference in newborns . Seizure 2009; 18: 672-5.
    • (2009) Seizure , vol.18 , pp. 672-675
    • Almgren, M.1    Källén, B.2    Lavebratt, C.3
  • 52
    • 51449100218 scopus 로고    scopus 로고
    • Maternal use of antipsychotics in early pregnancy and delivery outcome
    • Reis M, Källén B. Maternal use of antipsychotics in early pregnancy and delivery outcome . J Clin Psychopharmacol 2008; 28: 279-88.
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 279-288
    • Reis, M.1    Källén, B.2
  • 53
    • 41749113848 scopus 로고    scopus 로고
    • Maternal use of loperamide in early pregnancy and delivery outcome
    • Källén B, Nilsson E, Otterblad Olausson P. Maternal use of loperamide in early pregnancy and delivery outcome. Acta Paediatr 2008; 97: 541-5.
    • (2008) Acta Paediatr , vol.97 , pp. 541-545
    • Källén, B.1    Nilsson, E.2    Otterblad Olausson, P.3
  • 54
    • 33947142396 scopus 로고    scopus 로고
    • Use of anti -asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications
    • Källén B, Otterblad Olausson P. Use of anti -asthmatic drugs during pregnancy. 1. Maternal characteristics, pregnancy and delivery complications . Eur J Clin Pharmacol 2007; 63: 363-73.
    • (2007) Eur J Clin Pharmacol , vol.63 , pp. 363-373
    • Källén, B.1    Otterblad Olausson, P.2
  • 57
    • 4544264072 scopus 로고    scopus 로고
    • Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry
    • Covington DL, Tilson H, Elder J, Doi P. Assessing teratogenicity of antiretroviral drugs: monitoring and analysis plan of the Antiretroviral Pregnancy Registry . Pharmacoepidemiol Drug Saf 2004; 13: 537-45.
    • (2004) Pharmacoepidemiol Drug Saf , vol.13 , pp. 537-545
    • Covington, D.L.1    Tilson, H.2    Elder, J.3    Doi, P.4
  • 58
    • 84888714928 scopus 로고    scopus 로고
    • Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2009
    • Antiretroviral Pregnancy Registry Steering Committee, 2009. Wilmington, NC: Registry Coordinating Center (accessed June)
    • Antiretroviral Pregnancy Registry Steering Committee . Antiretroviral Pregnancy Registry International Interim Report for 1 January 1989 through 31 July 2009. Wilmington, NC: Registry Coordinating Center , 2009. http://www.APRegistry.com (accessed June 2011).
    • (2011)
  • 60
    • 84888729205 scopus 로고    scopus 로고
    • Public Workshop on Developing a Consolidated Pediatric Rheumatology Observational Registry
    • Center for Drug Evaluation and Research (CDER) (accessed May), May 12 - 13, 2009
    • Center for Drug Evaluation and Research (CDER) . Public Workshop on Developing a Consolidated Pediatric Rheumatology Observational Registry, May 12 - 13, 2009. http://www.fda.gov/downloads/Drugs/NewsEvents/ UCM171762.pdf(accessed May, 2010).
    • (2010)
  • 61
    • 84891367636 scopus 로고    scopus 로고
    • Postmarket Requirements and Commitments
    • Food and Drug Administration, United States Department of Health and Human Services (accessed May)
    • Food and Drug Administration, United States Department of Health and Human Services . Postmarket Requirements and Commitments. http://www.accessdata. fda.gov/scripts/cder/pmc/index.cfm (accessed May, 2010).
    • (2010)
  • 62
    • 65249090204 scopus 로고    scopus 로고
    • Association of physician certification and outcomes among patients receiving an implantable cardioverter -defibrillator
    • Curtis JP , Luebbart JJ, Wang Y, Rathmore SS, Chen J, Heidenreich PA , et al. Association of physician certification and outcomes among patients receiving an implantable cardioverter -defibrillator . JAMA 2009; 301: 1661-70.
    • (2009) JAMA , vol.301 , pp. 1661-1670
    • Curtis, J.P.1    Luebbart, J.J.2    Wang, Y.3    Rathmore, S.S.4    Chen, J.5    Heidenreich, P.A.6
  • 64
    • 43749121858 scopus 로고    scopus 로고
    • Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET registry
    • Hillner BE, Siegel BA, Liu D, Shields AF , Gareen IF , Hanna L, et al. Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET registry . J Clin Onc 2008; 26: 5316-19.
    • (2008) J Clin Onc , vol.26 , pp. 5316-5319
    • Hillner, B.E.1    Siegel, B.A.2    Liu, D.3    Shields, A.F.4    Gareen, I.F.5    Hanna, L.6
  • 65
    • 77953638697 scopus 로고    scopus 로고
    • Acting on comparative effectiveness research in COPD
    • Krishnan JA, Mularski RA. Acting on comparative effectiveness research in COPD . JAMA 2010; 303: 2409-10.
    • (2010) JAMA , vol.303 , pp. 2409-2410
    • Krishnan, J.A.1    Mularski, R.A.2
  • 66
  • 67
    • 84888689447 scopus 로고    scopus 로고
    • FDA ' s Sentinel Initiative: Transforming How we Monitor the Safety of FDA - related Products
    • Food and Drug Administration, United States Department of Health and Human Services (accessed May)
    • Food and Drug Administration, United States Department of Health and Human Services . FDA ' s Sentinel Initiative: Transforming How we Monitor the Safety of FDA - related Products. http://www.fda.gov/ Safety/FDAsSentinelInitiative/default.htm (accessed May, 2010).
    • (2010)
  • 69
    • 77954111739 scopus 로고    scopus 로고
    • 100 Initial Priority Topics for Comparative Effectiveness Research
    • Institute of Medicine (accessed May)
    • Institute of Medicine . 100 Initial Priority Topics for Comparative Effectiveness Research. http://www. iom.edu/~/media/Files/Report%20Files/2009/ ComparativeEffectivenessResearchPriorities/Stand% 20Alone%20List%20of%20100%20CER%20 Priorities%20-%20for%20web.ashx (accessed May, 2010).
    • (2010)
  • 70
    • 84888737730 scopus 로고    scopus 로고
    • Genzyme (accessed June)
    • Genzyme. Pompe Registry . https://www.lsdregistry. net/pomperegistry (accessed June, 2010).
    • (2010) Pompe Registry
  • 71
    • 84888714910 scopus 로고    scopus 로고
    • European Medicines Agency (accessed May)
    • European Medicines Agency . PROTECT . http:// www.imi -protect.eu (accessed May, 2010).
    • (2010) PROTECT
  • 72
    • 13544261627 scopus 로고    scopus 로고
    • A brief conceptual tutorial of multilevel analysis in social epidemiology: linking the statistical concept of clustering to the idea of contextual phenomenon
    • Merlo J, Chaix B, Yang M, Lynch J, Rastam L. A brief conceptual tutorial of multilevel analysis in social epidemiology: linking the statistical concept of clustering to the idea of contextual phenomenon . J Epidemiol Comm Health 2005; 59: 443-9.
    • (2005) J Epidemiol Comm Health , vol.59 , pp. 443-449
    • Merlo, J.1    Chaix, B.2    Yang, M.3    Lynch, J.4    Rastam, L.5
  • 73
    • 0033929727 scopus 로고    scopus 로고
    • Multilevel analysis in public health research
    • Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health 2000; 21: 171-92.
    • (2000) Annu Rev Public Health , vol.21 , pp. 171-192
    • Diez-Roux, A.V.1
  • 75
  • 76
    • 84888674002 scopus 로고    scopus 로고
    • Pfizer seeks ways to ease adverse events reporting digitally
    • March 30 (accessed May), 2010
    • Arnold M. Pfizer seeks ways to ease adverse events reporting digitally . Medical Marketing and Media, March 30, 2010 http://www.mmm -online.com/pfizer -seeksways-to-ease-adverse-events-reporting-digitally/ article/166947/ (accessed May, 2010).
    • (2010) Medical Marketing and Media
    • Arnold, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.